image


A00-280 Dumps

A00-280 Braindumps A00-280 Real Questions A00-280 Practice Test

A00-280 Actual Questions


SASInstitute


A00-280


Clinical Trials Programming Using SAS 9


https://killexams.com/pass4sure/exam-detail/A00-280


QUESTION: 92

A Statistical Analysis Plan (SAP) defines the selection process for baseline records. This instructs the programmer to choose the last non-missing analyte value prior to first study drug administration (date/time). The DEMO data set contains the date/time of first study drug administration for subject:

image

What will be the resulting baseline values, as selected per the SAP instructions?

image


  1. Option A

  2. Option B

  3. Option C

  4. Option D


Answer: D


QUESTION: 93

From the Statistical Analysis Plan, patients age is calculated as an integer relative to date randomized divided by 365.25. Given the following annotated CRF:


image

Which programming code defines the patient's age?


  1. age = int((birthdt-randdt)/365.25);

  2. age = int((randdt-birthdt)/365.25);

  3. age= int(yrdif(birthdt,randdt, "act/365.25" ));

  4. age = int((today()-birthdt)/365.25);


Answer: B


QUESTION: 94

An action plan that describes what will be done in a drug study, how it will be conducted, and why each part of the study is necessary is called:


  1. a clinical trial plan

  2. a protocol

  3. a data management plan

  4. a statistical analysis plan


Answer: B


QUESTION: 95

What is the main focus of 21 CFR Part 11?


  1. electronic submission requirements

  2. trial safety requirements


  3. statistical calculation requirements

  4. trial protocol requirements


Answer: A


QUESTION: 96

What is an international ethical and scientific quality standard for designing, conducting, recording and reporting trials that involve the participation of human subjects?


  1. 21 CFR Part 11

  2. Good Clinical Practices

  3. MedDRA

  4. WHODrug


Answer: B


QUESTION: 97

A patient received at least one dose of study medication prior to withdrawing from a study. Which analysis population would always include this patient?


  1. efficacy

  2. intent to treat

  3. per protocol

  4. safety


Answer: D


QUESTION: 98

A Statistical Analysis Plan describes a clinical trial as "A 12 week, double-blind, placebo- controlled, randomized, multi-center study." Double-blind refers to which groups in this study?


  1. treatment and control group

  2. investigator and subjects

  3. statistician and sponsor

  4. sponsor and investigator


Answer: B


QUESTION: 99

Given the following SAS program:

image

Which statement correctly identifies invalid values in the variable TRT, if only the values 'A', B', 'C are valid?


  1. if indexc(TRT, 'ABC') eq 0 then output;

  2. if index(TRT, 'ABC') eq 0 then output;

  3. if find(TRT, 'ABC') eq 0 then output;

  4. if indexw(TRT, 'ABC') eq 0 then output;


Answer: A


image

6$03/( 48(67,216


7KHVH TXHVWLRQV DUH IRU GHPR SXUSRVH RQO\ )XOO YHUVLRQ LV XS WR GDWH DQG FRQWDLQV DFWXDO TXHVWLRQV DQG DQVZHUV


.LOOH[DPV FRP LV DQ RQOLQH SODWIRUP WKDW RIIHUV D ZLGH UDQJH RI VHUYLFHV UHODWHG WR FHUWLILFDWLRQ H[DP SUHSDUDWLRQ 7KH SODWIRUP SURYLGHV DFWXDO TXHVWLRQV H[DP GXPSV DQG SUDFWLFH WHVWV WR KHOS LQGLYLGXDOV SUHSDUH IRU YDULRXV FHUWLILFDWLRQ H[DPV ZLWK FRQILGHQFH +HUH DUH VRPH NH\ IHDWXUHV DQG VHUYLFHV RIIHUHG E\ .LOOH[DPV FRP


$FWXDO ([DP 4XHVWLRQV .LOOH[DPV FRP SURYLGHV DFWXDO H[DP TXHVWLRQV WKDW DUH H[SHULHQFHG LQ WHVW FHQWHUV 7KHVH TXHVWLRQV DUH XSGDWHG UHJXODUO\ WR HQVXUH WKH\ DUH XS WR GDWH DQG UHOHYDQW WR WKH ODWHVW H[DP V\OODEXV %\ VWXG\LQJ WKHVH DFWXDO TXHVWLRQV FDQGLGDWHV FDQ IDPLOLDUL]H WKHPVHOYHV ZLWK WKH FRQWHQW DQG IRUPDW RI WKH UHDO H[DP


([DP 'XPSV .LOOH[DPV FRP RIIHUV H[DP GXPSV LQ 3') IRUPDW 7KHVH GXPSV FRQWDLQ D FRPSUHKHQVLYH FROOHFWLRQ RI TXHVWLRQV DQG DQVZHUV WKDW FRYHU WKH H[DP WRSLFV %\ XVLQJ WKHVH GXPSV FDQGLGDWHV FDQ HQKDQFH WKHLU NQRZOHGJH DQG LPSURYH WKHLU FKDQFHV RI VXFFHVV LQ WKH FHUWLILFDWLRQ H[DP


3UDFWLFH 7HVWV .LOOH[DPV FRP SURYLGHV SUDFWLFH WHVWV WKURXJK WKHLU GHVNWRS 9&( H[DP VLPXODWRU DQG RQOLQH WHVW HQJLQH 7KHVH SUDFWLFH WHVWV VLPXODWH WKH UHDO H[DP HQYLURQPHQW DQG KHOS FDQGLGDWHV DVVHVV WKHLU UHDGLQHVV IRU WKH DFWXDO H[DP 7KH SUDFWLFH WHVWV FRYHU D ZLGH UDQJH RI TXHVWLRQV DQG HQDEOH FDQGLGDWHV WR LGHQWLI\ WKHLU VWUHQJWKV DQG ZHDNQHVVHV


*XDUDQWHHG 6XFFHVV .LOOH[DPV FRP RIIHUV D VXFFHVV JXDUDQWHH ZLWK WKHLU H[DP GXPSV 7KH\ FODLP WKDW E\ XVLQJ WKHLU PDWHULDOV FDQGLGDWHV ZLOO SDVV WKHLU H[DPV RQ WKH ILUVW DWWHPSW RU WKH\ ZLOO UHIXQG WKH SXUFKDVH SULFH 7KLV JXDUDQWHH SURYLGHV DVVXUDQFH DQG FRQILGHQFH WR LQGLYLGXDOV SUHSDULQJ IRU FHUWLILFDWLRQ H[DPV


8SGDWHG &RQWHQW .LOOH[DPV FRP UHJXODUO\ XSGDWHV LWV TXHVWLRQ EDQN DQG H[DP GXPSV WR HQVXUH WKDW WKH\ DUH FXUUHQW DQG UHIOHFW WKH ODWHVW FKDQJHV LQ WKH H[DP V\OODEXV 7KLV KHOSV FDQGLGDWHV VWD\ XS WR GDWH ZLWK WKH H[DP FRQWHQW DQG LQFUHDVHV WKHLU FKDQFHV RI VXFFHVV


7HFKQLFDO 6XSSRUW .LOOH[DPV FRP SURYLGHV IUHH [ WHFKQLFDO VXSSRUW WR DVVLVW FDQGLGDWHV ZLWK DQ\ TXHULHV RU LVVXHV WKH\ PD\ HQFRXQWHU ZKLOH XVLQJ WKHLU VHUYLFHV 7KHLU FHUWLILHG H[SHUWV DUH DYDLODEOH WR SURYLGH JXLGDQFH DQG KHOS FDQGLGDWHV WKURXJKRXW WKHLU H[DP SUHSDUDWLRQ MRXUQH\


'PS .PSF FYBNT WJTJU IUUQT LJMMFYBNT DPN WFOEPST FYBN MJTU

.LOO \RXU H[DP DW )LUVW $WWHPSW *XDUDQWHHG